As an innovative late-stage company, our efforts are built around the needs of patients and their loved ones. We approach our work every day with the goal of improving health outcomes and easing the disease burden for patients with rare endocrine disorders.
We listen intently to what the patient community tells us about living with conditions such as CAH, and aim to address these needs in our development programs. We have adapted our clinical trial programs to ensure the utmost safety and flexibility for participants as well as caregivers in the era of COVID-19.
To learn more about Spruce advocacy or to ask us a question, we invite patient and family caregiver advocates to connect with us at email@example.com.